FDA Inspection 1300772 — American Regent, Inc.

American Regent, Inc. — FEI 3010209784

The FDA completed an inspection of American Regent, Inc. on Jan 29, 2026 in New Albany, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 29, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Albany, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
145121 CFR 211.113(b)Procedures for sterile drug products
185121 CFR 211.84(e)Rejecting When Specifications Not Met
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.